TAFASITAMAB

U.S. Department of Health & Human Services Divider Arrow

National Institutes of Health Divider Arrow

NCATS

Approval Year

Name

Type

Language

TAFASITAMAB

Official Name

English

MOR-208

Common Name

English

TAFASITAMAB [WHO-DD]

Common Name

English

XMAB5574

Common Name

English

TAFASITAMAB [USAN]

Common Name

English

MOR-00208

Code

English

HUMANIZED FC ENGINEERED MONOCLONAL ANTIBODY AGAINST CD19

Common Name

English

IMMUNOGLOBULIN, ANTI-(HUMAN CD19 ANTIGEN) (HUMAN-MUS MUSCULUS MONOCLONAL MOR00208 HEAVY CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL MOR00208 .KAPPA.-CHAIN, DIMER

Common Name

English

MOR00208

Code

English

XMAB-5574

Common Name

English

TAFASITAMAB [INN]

Common Name

English

Classification Tree Code System Code

FDA ORPHAN DRUG

456014

Created by admin on Sat Jun 26 17:21:35 UTC 2021 , Edited by admin on Sat Jun 26 17:21:35 UTC 2021

EU-Orphan Drug

EU/3/17/1962

Created by admin on Sat Jun 26 17:21:35 UTC 2021 , Edited by admin on Sat Jun 26 17:21:35 UTC 2021

FDA ORPHAN DRUG

427914

Created by admin on Sat Jun 26 17:21:35 UTC 2021 , Edited by admin on Sat Jun 26 17:21:35 UTC 2021

Code System Code Type Description

DRUG BANK

DB15044

Created by admin on Sat Jun 26 17:21:35 UTC 2021 , Edited by admin on Sat Jun 26 17:21:35 UTC 2021

PRIMARY

CAS

1422527-84-1

Created by admin on Sat Jun 26 17:21:35 UTC 2021 , Edited by admin on Sat Jun 26 17:21:35 UTC 2021

PRIMARY

RXCUI

2387211

Created by admin on Sat Jun 26 17:21:35 UTC 2021 , Edited by admin on Sat Jun 26 17:21:35 UTC 2021

PRIMARY

INN

10835

Created by admin on Sat Jun 26 17:21:35 UTC 2021 , Edited by admin on Sat Jun 26 17:21:35 UTC 2021

PRIMARY

NCI_THESAURUS

C95768

Created by admin on Sat Jun 26 17:21:35 UTC 2021 , Edited by admin on Sat Jun 26 17:21:35 UTC 2021

PRIMARY

FDA UNII

QQA9MLH692

Created by admin on Sat Jun 26 17:21:35 UTC 2021 , Edited by admin on Sat Jun 26 17:21:35 UTC 2021

PRIMARY

ACTIVE MOIETY


					QQA9MLH692